Cytokinetics Inc (CYTK)
64.80
-2.02
(-3.02%)
USD |
NASDAQ |
Apr 25, 16:00
64.85
+0.05
(+0.08%)
After-Hours: 20:00
Cytokinetics Total Liabilities (Quarterly): 1.211B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.211B |
| September 30, 2023 | 1.179B |
| June 30, 2023 | 1.113B |
| March 31, 2023 | 1.119B |
| December 31, 2022 | 1.123B |
| September 30, 2022 | 1.092B |
| June 30, 2022 | 660.30M |
| March 31, 2022 | 739.99M |
| December 31, 2021 | 597.46M |
| September 30, 2021 | 578.52M |
| June 30, 2021 | 547.81M |
| March 31, 2021 | 509.22M |
| December 31, 2020 | 420.42M |
| September 30, 2020 | 324.51M |
| June 30, 2020 | 310.58M |
| March 31, 2020 | 302.29M |
| December 31, 2019 | 300.75M |
| September 30, 2019 | 207.26M |
| June 30, 2019 | 203.11M |
| March 31, 2019 | 195.24M |
| December 31, 2018 | 185.24M |
| September 30, 2018 | 178.21M |
| June 30, 2018 | 172.07M |
| March 31, 2018 | 180.33M |
| December 31, 2017 | 184.97M |
| Date | Value |
|---|---|
| September 30, 2017 | 179.28M |
| June 30, 2017 | 165.63M |
| March 31, 2017 | 169.99M |
| December 31, 2016 | 75.78M |
| September 30, 2016 | 74.92M |
| June 30, 2016 | 57.42M |
| March 31, 2016 | 55.31M |
| December 31, 2015 | 46.65M |
| September 30, 2015 | 34.90M |
| June 30, 2015 | 37.84M |
| March 31, 2015 | 38.06M |
| December 31, 2014 | 40.90M |
| September 30, 2014 | 13.56M |
| June 30, 2014 | 17.45M |
| March 31, 2014 | 21.10M |
| December 31, 2013 | 28.75M |
| September 30, 2013 | 48.26M |
| June 30, 2013 | 42.57M |
| March 31, 2013 | 6.26M |
| December 31, 2012 | 7.466M |
| September 30, 2012 | 4.742M |
| June 30, 2012 | 4.10M |
| March 31, 2012 | 4.524M |
| December 31, 2011 | 4.595M |
| September 30, 2011 | 5.034M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
203.11M
Minimum
Jun 2019
1.211B
Maximum
Dec 2023
659.93M
Average
578.52M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 90.92B |
| Johnson & Johnson | 98.78B |
| Eli Lilly and Co | 53.14B |
| Viking Therapeutics Inc | 33.63M |
| Madrigal Pharmaceuticals Inc | 235.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 824.32M |
| Shareholders Equity (Quarterly) | -386.32M |
| Debt to Equity Ratio | -1.598 |
| Current Ratio | 6.117 |
| Net Debt Paydown Yield | -0.02% |